Evidence map›Paper›PMID 42022736›Full record

ReviewEuropean journal of radiology open2026

Machine learning and deep learning models for predicting colorectal cancer metastases: A comprehensive review.

Mikiyas Amare Getu, Tesfaye Amare, Kefeng Li, Anam Mehmood, Yonas Fissha Adem, Pablo Santos, Hu Yan

Abstract readReview
In one paragraph

Review in European journal of radiology open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mikiyas Amare GetuFudan University, School of Nursing, Shanghai, China.
Tesfaye AmareFaculty of Technology, Woldia University,Ethiopia.
Kefeng LiFaculty of Applied Sciences, Macao Polytechnic University, Macao Special Administrative Region of China.
Anam MehmoodSchool of Psychology, Sichuan Normal University, Chendgu, China.
Yonas Fissha AdemDepartment of Public Health, Dessie College of Health Sciences, Dessie, Ethiopia.
Pablo SantosGlobal and Planetary Health Working Group, Institute of Medical Epidemiology, Biostatistics and Informatics, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
Hu YanFudan University, School of Nursing, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide, largely due to the development of distant metastases, which is associated with poor survival outcomes. Early detection and accurate prediction of colorectal cancer metastasis can significantly improve patient outcomes. Conventional diagnostic approaches, including imaging and biomarkers, are often limited by suboptimal sensitivity and inter-observer variability. In recent years, machine learning (ML) and deep learning (DL) models have emerged as powerful tools capable of analyzing complex, high-dimensional clinical, imaging, and molecular data to enhance metastasis prediction. This review provides a comprehensive overview of ML and DL approaches for the early prediction of CRC metastasis, highlighting gaps in comparative studies. We explore DL techniques, including convolutional neural networks (CNNs), and alternative approaches, along with their architectures and layer types. The most commonly used CNN models such as GoogleNet, VGGNet, ResNet, and U-Net have demonstrated effectiveness in identifying complex patterns of data. These predictive models have improved individualized treatment strategies, leading to enhanced patient outcomes owing to the integration of multi-modal data including imaging, clinical data, histological data and employing transfer learning. This review also examines the applications of ML and DL in predicting CRC metastasis to specific sites such as lymph nodes, liver, lungs, bones, and peritoneum. While traditional ML algorithms, including logistic regression and random forests remain valuable, DL models incorporating radiomics and transfer learning, often achieve superior performance. Finally, we explore how the computational costs and resource implications of ML and DL technologies need attention in clinical contexts. Challenges such as the availability of high-quality datasets, interpretability, and ethical concerns are examined, and appropriate solutions are discussed. Future research should focus on developing explainable ML/DL models, optimizing computational resources, establishing ethical frameworks, validation of model performance across diverse populations, along with the incorporation of molecular and genomic data.

Indexed as

Artificial intelligenceCancerDeep learningMachine learningMetastasis

Identifiers

PMID42022736
PMCPMC13096892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.